Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Remote Patient Monitoring Market - Outlook and Forecast 2022-2027
The global remote patient monitoring market, valued at USD 30 billion in 2021, is projected to reach USD 62 billion with a CAGR of 12.5% during the forecast period. The market is expected to experience significant growth due to the rising demand for remote patient monitoring systems and devices amidst the COVID-19 pandemic.
Key drivers of the global remote patient monitoring market include technological advancements, a growing emphasis on public health, increased consumer awareness about the benefits of remote patient monitoring, and decreasing prices. Traditional medical device manufacturers are also expanding their product portfolios by introducing remote patient monitoring devices integrated with advanced technologies like the Internet of Things (IoT).
|No. of Pages||
USD 30.6 billion in 2020
Component, Application, End-User, and Geography
|No. of Companies Mentioned||
Remote patient monitoring involves using digital technologies to monitor and collect medical data from patients, which is then transmitted electronically to healthcare providers for assessment and recommendations as needed. This approach reduces readmissions, hospitalizations, and length of hospital stays, leading to improved quality of life and cost containment.
In 2020, chronic diseases and related disorders accounted for nearly three-quarters of global deaths. Developing countries experienced high mortality rates, with 71% of deaths due to ischemic heart disease (IHD), 75% due to stroke, and 70% due to diabetes. The number of people with diabetes in developing nations is expected to more than double by 2025, reaching 228 million.
According to the Centers for Disease Control and Prevention, six out of ten adults in the US suffer from a chronic illness, and by 2025, it is projected that 164 million people, or 49% of the population, will have chronic diseases. Multidisciplinary teams in primary care and public health play a vital role in preventing and managing chronic diseases. Furthermore, the number of people with persistent mental disorders is estimated to increase from 30 million to 47 million by 2023, according to Project HOPE: The People-to-People Health Foundation, Inc. Similar rates of growth are expected for other prevalent chronic illnesses.
The demand for remote patient monitoring devices has seen a steady increase due to the rising number of COVID-19 patients in hospitals worldwide. There is a particular surge in demand among patients with chronic conditions. Increased awareness about COVID-19 and concerns about the risk of infection during hospital visits are driving the growth of the global remote patient monitoring market.
The market is segmented based on various factors, including component, application, end-user, and geography.
Segmentation by Component:
Devices and Software – Cardiac Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitors, Fetal & neonatal monitoring devices, Other RPM
Segmentation by Application
Segmentation by End-User
Hospitals & Specialty Clinics
Home Care Settings
Ambulatory Surgical Centers
Long-term & Acute Care Centers
Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey
The Devices and Software segment holds the largest share in the global remote patient monitoring (RPM) market. Cardiology, being one of the first specialties to adopt RPM, has benefitted from the emergence of connected cardiac implants. Cardiology practices are well-positioned to capitalize on the short and long-term advantages offered by the advancement of RPM services, technology, and regulations. The cardiac monitoring market is further driven by innovative product features and the increased demand for virtual care solutions in the COVID-19 era. In fact, the cardiac monitor segment accounts for the highest share in the RPM market. For instance, according to the CDC, 30.3 million US adults were diagnosed with heart disorders in 2018, highlighting the significant prevalence of cardiac disorders that will drive the growth of this segment.
While RPM has gained popularity, there are still individuals who remain unfamiliar with the concept. RPM is a covered service that utilizes digital technologies and electronic monitoring to encourage patients to play a more active role in managing their health, while also enabling healthcare practitioners to collect crucial patient data between in-office visits. RPM has various important applications in cardiology, including hypertension and medication management, as well as weight monitoring for congestive heart failure patients.
Cardiology treatment sees a greater application of RPM devices compared to pulmonology and endocrinology. Cardiology RPM programs enable cardiologists to enhance treatment efficiency and time management, which are two significant benefits reported by cardiologists. By easily tracking crucial patient data and reducing the frequency of in-office visits for certain patients, cardiologists can effectively support a larger patient base while mitigating burnout-related stress. RPM also enhances the likelihood of early detection and resolution of impending health crises, providing practitioners with deeper insights into patients’ lifestyles and triggers and enabling informed treatment adjustments.
Hospitals and specialty clinics contribute the majority of revenue to the RPM market as RPMs are primarily used in these settings. The adoption of RPM, coupled with centralized virtual care teams in hospitals and clinics, has significantly reduced hospital readmission rates and decreased overall acute care resource utilization among acutely ill patients. Continuous remote monitoring of hospitalized patients in general medical settings not only improves outcomes but also automates the collection and documentation of patients’ vital signs, reducing the burden on overworked and under-resourced staff. When integrated into electronic health records (EHR), this automation further increases accuracy and efficiency. These factors drive the adoption of RPM devices and software in hospitals and clinics, thereby fostering market growth.
North America holds a significant 40% share in the global remote patient monitoring market as of 2021. The presence of major competitors and their growth strategies are key factors propelling the North American market. Rising healthcare spending and increased awareness of the benefits of illness prevention contribute to market growth. Additionally, the prevalence of heart diseases, sedentary lifestyles, and the deployment of e-health technologies in rural areas of North America are expected to drive further market expansion. The government’s efforts to introduce telehealth technology in rural regions and the presence of prominent corporations also contribute to the growth of the market in this region.
The global remote patient monitoring market exhibits a certain degree of fragmentation, with numerous prominent companies operating at a global level and several smaller players focusing on regional markets. The key competitors in this market are actively engaged in strategies aimed at expanding their market share and driving the growth of the remote patient monitoring market as a whole. These strategies include the introduction of innovative products and forging strategic collaborations with other participants in the market.
When it comes to devices and software, Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies in the industry. Additionally, Withings, MedM, iHealthUnifiedcare, and Qardio are also recognized as top players in this sector.
Key companies profiled in this report include Medtronic, Philips Healthcare, ResMed, Resideo, Honeywell, LST (LifeScience Technologies), Coforge, Withings, MedM, iHealthUnifiedcare, Qardio, 100-Plus, A&D, Abbott, AltumView Systems, Biotronik, Boston Scientific, Bardy Diagnostics, Cardiomo, Cardiologs, Dragerwerk AG, Hoffmann-La Roche, GE Healthcare, GrandCare, Masimo Corporation, Medopad, Nihon Kohden, Omron Healthcare, OSPLabs, Smiths Medical, Spacelabs, Senseonics, TeleMedCare, VitalConnect, Vitls, Modicare, Hillrom, Vivify Health, ACL Digital, Dexcom, iRhythm Technologies, Vivalink, Biobeat, CareValidate, Biofourmis, CAREMINDr, Datos Health.
Recent Industry Developments
In August 2020, Stasis Labs introduced a mobile-connected remote patient monitoring technology for implementation in hospitals and outpatient settings across the United States. The Stasis system effectively monitors crucial vital parameters to ensure its optimal functionality.
In July 2020, Philips and BioIntelliSense joined forces to enhance remote patient monitoring systems for at-risk patients transitioning from hospitals to their homes. Philips incorporated the BioIntelliSense sensor into their devices to enable remote usage.
Phillips launched Tempus ALS, a wireless monitoring solution for pre-hospital care, in the United States in July 2020. This solution includes a remote professional defibrillator called Tempus LS-Manual and a portable vital signs monitor known as Tempus Pro.
In March 2020, the United States government announced an allocated funding of USD 500 million over a period of ten years to support a remote healthcare initiative. This financing authorization signifies the government’s interest in incorporating remote patient monitoring (RPM) into the national healthcare system.
To enhance telemedicine capabilities, T-Mobile installed 5G technology in the Miami Veterans Affairs (VA) Healthcare System in February 2021.
In April 2021, Verizon released BlueJeans Telehealth, a virtual care platform that complies with HIPAA regulations.
In May 2021, Boost Mobile, a subsidiary of Dish Network, collaborated with digital health startup K Health to provide free telehealth services to users of its Unlimited Plus plan.
Key Questions Answered
What is the market size of remote patient monitoring?
The remote patient monitoring market had a valuation of USD 30.56 billion in 2021, and it is projected to reach USD 61.78 billion by 2027.
What is the growth rate of the remote patient monitoring system market?
The remote patient monitoring market is anticipated to grow at a compound annual growth rate (CAGR) of 12.5% during the period from 2021 to 2027.
Who are the major players in the remote patient monitoring market?
Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies in the global remote patient monitoring market for devices and software.
Which region will dominate the global remote patient monitoring market?
North America is expected to remain the dominant market for remote patient monitoring due to the increasing healthcare expenditure in the region.
What is the primary strategy adopted by remote patient monitoring companies to enhance their market share?
Mergers and acquisitions are the primary strategies that companies in the global remote patient monitoring devices industry are focusing on to increase their market share.